Results 61 to 70 of about 5,602,030 (205)

Randomized phase II study of stereotactic body radiotherapy and interleukin-2 versus interleukin-2 in patients with metastatic melanoma

open access: yesJournal for ImmunoTherapy of Cancer, 2020
Background A pilot study of stereotactic body radiation therapy (SBRT) followed by high-dose interleukin-2 (IL-2) showed a higher than anticipated objective response rate (ORR) among patients with metastatic melanoma (MM).
Marka Crittenden   +10 more
doaj   +1 more source

Statin use and survival in resectable pancreatic cancer: confounders and mechanisms. [PDF]

open access: yes, 2016
A first point regards the possible activity of drugs other than statins, such as aspirin or metformin, against pancreatic cancer. As many patients use a combination of these drugs, one might speculate that the association between simvastatin and overall ...
Archibugi, L   +2 more
core   +1 more source

PB2349: A PHASE 1, OPEN-LABEL, MULTICENTER, DOSE-ESCALATION STUDY OF SGR-1505 AS MONOTHERAPY IN SUBJECTS WITH MATURE B-CELL MALIGNANCIES

open access: yesHemaSphere, 2023
Adam Olszewski   +9 more
doaj   +1 more source

Nucleosomes indicate the in vitro radiosensitivity of irradiated bronchoepithelial and lung cancer cells [PDF]

open access: yes, 2004
Nucleosomes, which are typical cell death products, are elevated in the serum of cancer patients and are known to rapidly increase during radiotherapy.
Al-Batran SE   +14 more
core   +1 more source

T057: Circulating tumor DNA in classical Hodgkin lymphoma patients treated with pembrolizumab and chemotherapy: dynamic response assessment and correlation with baseline total metabolic tumor volume

open access: yesHemaSphere, 2022
Ryan C. Lynch   +26 more
doaj   +1 more source

Transient increase in skeletal-related events after discontinuation of high-dose denosumab in cancer patients

open access: yesJournal of Bone Oncology
Background: Denosumab is widely used to prevent skeletal-related events (SREs) in patients with bone metastases. However, rebound bone resorption after discontinuation is recognized.
Nokitaka Setsu   +5 more
doaj   +1 more source

Two Cases of Ectopic Hamartomatous Thymoma Masquerading as Sarcoma

open access: yesCase Reports in Otolaryngology, 2017
Ectopic hamartomatous thymoma (EHT) is an extremely rare benign tumor. EHTs are difficult to differentiate from sarcomas, especially synovial sarcomas. We encountered two cases of EHT that were referred from other hospitals because sarcoma was suspected.
Takahito Kondo   +8 more
doaj   +1 more source

Do changes in health reveal the possibility of undiagnosed pancreatic cancer? Development of a risk-prediction model based on healthcare claims data. [PDF]

open access: yes, 2019
Background and objectiveEarly detection methods for pancreatic cancer are lacking. We aimed to develop a prediction model for pancreatic cancer based on changes in health captured by healthcare claims data.MethodsWe conducted a case-control study on 29 ...
Baecker, Aileen   +8 more
core   +2 more sources

Toward optimal implementation of cancer prevention and control programs in public health: A study protocol on mis-implementation [PDF]

open access: yes, 2018
Background Much of the cancer burden in the USA is preventable, through application of existing knowledge. State-level funders and public health practitioners are in ideal positions to affect programs and policies related to cancer control.
A McGowan   +107 more
core   +2 more sources

Infection with hepatitis viruses, FIB-4 index and risk of hepatocellular carcinoma in southern Italy: a population-based cohort study

open access: yesInfectious Agents and Cancer, 2016
Background The incidence of hepatocellular carcinoma (HCC) and its association with hepatitis C (HCV) and hepatitis B virus (HBV) infections, FIB-4 index and liver enzymes was assessed in an area of the province of Naples covered by a population-based ...
Mario Fusco   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy